Business

Sterilization Compatibility for Injection-Molded Medical Resins

Medical resin sterilization cover with identical molded components under four controlled exposure methods

That distinction matters because sterilization can change a polymer without producing an immediate crack. Steam can combine heat, moisture, and mechanical constraint. Ionizing radiation can change molecular structure and color. Ethylene oxide (EtO) can leave residuals that require controlled aeration and release. The effect may appear as dimensional drift, loss of ductility, discoloration, environmental stress cracking, or a changed chemical profile rather than an obvious one-cycle failure.

The selection logic for medical grade plastics injection molding should therefore run in this order: define the sterilization exposure, identify the device’s biological-contact requirements, shortlist supported grades, mold the real geometry, and validate the finished device through its claimed life.

Replace the Compatibility Checkmark With an Exposure Specification

A supplier’s compatibility statement is a screening input. It is not a device-life claim unless the test conditions and acceptance criteria match the intended product.

At minimum, define:

  • Method: moist heat, EtO, gamma, electron beam (e-beam), or another validated modality.
  • Exposure: temperature and dwell for moist heat; minimum and maximum absorbed dose for radiation; process concentration, humidity, temperature, aeration, and residual-release controls for EtO.
  • Repetition: one terminal exposure, a limited number of reprocessing cycles, or a reusable-device life claim.
  • State: molded and finished device, including colorant, additives, joining, printing, cleaning, packaging, and any mold-release residue.
  • Acceptance: dimensions, seal integrity, torque, tensile or flexural behavior, impact resistance, snap retention, transparency, color, chemical characterization, and any device-specific function.
  • Aging point: immediately after sterilization and, where relevant, after real-time or accelerated aging.

This approach is consistent with AAMI TIR17:2024, an FDA-recognized technical report that addresses qualification of polymeric materials across radiation, EtO, steam, and several other modalities.[1] For steam processes, ISO 17665:2024 addresses development, validation, and routine control of moist-heat sterilization; it does not turn a generic polymer-family checkmark into evidence for a particular molded device.[2]

What the Four Common Methods Do to Plastics

Moist Heat: Temperature, Water, and Restraint Act Together

Steam sterilization is demanding because the part encounters elevated temperature in a wet environment, often while assembled or mechanically constrained. A material may remain visually acceptable yet lose ductility, change dimensions, or accumulate residual stress over repeated cycles.

Repeated steam therefore favors grades with demonstrated hydrolytic stability and adequate property retention at the specified cycle. It also makes molded-in stress important: sharp corners, thick-to-thin transitions, high packing stress, weld lines, and metal inserts can cause the device to age differently from a standard test bar.

Supplier data illustrate why the grade and conditions belong in the requirement. Syensqo states that its Radel PPSU healthcare offering can withstand more than 1,000 steam cycles without significant property loss, while limiting its cited ISO 10993-tested use to exposures of less than 24 hours to bodily fluids and tissue.[3] SABIC describes ULTEM HU1004 polyetherimide (PEI) as compatible with steam autoclaving up to 134°C and certain other sterilization methods, but its own document also defines particular biocompatibility tests and medical-use restrictions.[4] By contrast, Covestro’s Makrolon 2458 polycarbonate page identifies EtO and steam at 121°C for that specific injection-molding grade; it does not claim that every polycarbonate tolerates every autoclave cycle or reusable life.[5]

The engineering conclusion is not that one family “wins.” It is that cycle count, temperature, formulation, and the definition of acceptable change must travel with the grade name.

Ethylene Oxide: Lower Temperature Does Not Eliminate Validation

EtO is used for devices that may be damaged by heat or that contain narrow or difficult-to-reach regions. FDA notes that certain polymers and complex, multilayered devices may rely on EtO because it can sterilize without damaging the device in the way another method might.[6]

The main material question is broader than immediate mechanical compatibility. EtO and ethylene chlorohydrin residuals must be controlled. ISO 10993-7:2026, published in April 2026, specifies allowable limits, measurement procedures, and conformity methods for EO-sterilized devices.[7] Resin sorption, part thickness, packaging, and device geometry can affect aeration behavior, so a material coupon cannot by itself establish release time for the finished product.

Gamma Radiation: Dose Is a Material Input

Gamma sterilization exposes the device and packaging to ionizing radiation. In polymers, radiation can promote both chain scission and crosslinking; oxidation, embrittlement, and color change depend on the formulation, dose, atmosphere, and time after exposure. The International Atomic Energy Agency recommends assessing the finished device, packaging, aging behavior, and functional performance rather than relying only on base-resin data.[8]

Qualification should cover the allowed dose range, especially the maximum dose a product location may receive. A grade that survives the nominal sterilization dose may still fail a functional or aesthetic criterion at the validated maximum, after aging, or after repeat exposures.

Interpret retained-property changes as a set. If tensile strength or stiffness rises after a thermal exposure while elongation or impact performance falls, do not call the material simply “improved.” That pattern can be consistent with a changed molecular or morphological state, stress relaxation, or test variation while ductility is being lost. Retest a conditioned control and production-intent molded parts; compare strength, elongation, impact or device function, dimensions, and, when mechanism matters, thermal analysis such as DSC. The acceptance decision belongs to the device requirement, not to whichever single value increased.

E-Beam: Similar Chemistry, Different Delivery

E-beam is also ionizing radiation, so the same possible molecular changes deserve evaluation. It delivers dose at a higher rate and has different penetration behavior from gamma. Those differences can change dose distribution and material response, particularly in dense products or complex packaging configurations.[8]

It is unsafe to translate a gamma compatibility statement automatically into an e-beam approval. The change should be assessed against the actual device, packaging configuration, maximum dose, dose distribution, and functional requirements.

Four-panel comparison of moist heat, low-temperature gas, gamma, and electron-beam sterilization exposures

A Grade-Specific Screening Matrix

The table below is a starting point for questions, not a substitute for a supplier declaration or device validation.

CandidateSteam screening questionEtO screening questionRadiation screening questionMain molded-part risk to validate
PPSUDoes the exact healthcare grade have cycle-retention data at the intended temperature?Are residual release and packaging validated for the geometry?Are gamma/e-beam dose limits available for the grade and color?Impact retention, dimensions, color, chemical exposure after repeated cleaning and steam
PEIDoes the exact grade support the specified 121°C or 134°C cycle and repetition?Is the complete device compatible with processing and aeration?Does the supplier support the intended dose range and aging claim?Ductility, color, stress cracking, weld-line and snap performance
PEEK/PAEKAre medical-grade data available for the exact formulation, not only the polymer family?Does the supplier’s regulatory support cover the intended contact and duration?What dose-dependent property and color changes occur after aging?Crystallinity-related dimensions, molding history, joint and insert stresses
PolycarbonateIs the grade limited to a stated steam temperature or number of cycles?Does the grade and device geometry meet EtO residual and function requirements?Is it a radiation-stabilized grade, and what is the maximum qualified dose?Environmental stress cracking, ductility, optical change, assembly preload
POM/acetalIs repeat-steam support documented for the exact medical grade?Are residuals and any lubricated formulation constituents addressed?Is radiation support explicit for the grade rather than inferred from other acetals?Dimensional change, oxidation, wear behavior, additive and colorant effects
PA/nylonHow will moisture uptake and conditioning be controlled before measurement?Does aeration and chemical characterization represent the finished part?Does the grade have dose and aging data at the intended humidity?Moisture-driven dimensions, stiffness, assembly fit, conditioning-dependent test results
ElastomerWhat does the compound supplier report for repeated steam, including compression set?How quickly does the finished seal release residuals?What happens to hardness, elongation, compression set, and extractables at maximum dose?Seal force and leakage; family-level compatibility is not enough

The matrix deliberately avoids assigning universal pass/fail ratings. Formulation can change performance within the same polymer family. Stabilizers, pigments, fillers, internal lubricants, and processing history can alter radiation response, hydrolytic stability, residual sorption, and biological evaluation.

Biocompatibility Belongs to the Finished Device

As of August 2026, ISO 10993-1:2025 is the current international edition. FDA partially recognized it on May 25, 2026 and published implementation notes, including points that may not align completely with the agency’s existing endpoint matrix.[9] Regulatory teams should therefore verify both the current standard and the requirements of the target market rather than relying on an old generic “ISO 10993 compliant” statement.

More importantly, ISO 10993 is a risk-based biological evaluation framework, not one certificate that a resin either possesses or lacks. FDA guidance recommends evaluating the medical device in its final finished form, including sterilization when applicable. If a representative article is used, it should reflect the same formulation, manufacturing and sterilization processes, physical and surface properties, and material proportions.[10]

That means a supplier’s pre-assessment can reduce uncertainty but cannot automatically cover:

  • a new pigment or radiopaque filler;
  • an internal lubricant, adhesive, ink, or overmold;
  • regrind or cross-contamination;
  • cleaning chemistry or mold-release residue;
  • processing degradation from drying, residence time, or melt temperature;
  • sterilization-induced degradation products; or
  • a new body-contact type, duration, or regulatory jurisdiction.

For injection molding, formulation control and process control are therefore part of biological-risk control. A late resin, colorant, release-agent, or sterilization change can affect material qualification, device performance, chemical characterization, and the evidence expected in a submission.

Finished-device validation chain from resin and molded component to packaged device and extraction testing

A Selection and Validation Sequence That Avoids Dead Ends

  1. Freeze the sterilization claim first. Define modality, process range, maximum exposure, repeat count, packaging, and whether healthcare reprocessing includes cleaning and disinfection before each cycle.
  2. Classify biological contact. Record whether contact is direct or indirect, the tissue or body fluid involved, whether a contacted surface is intact or compromised, the location, repeated or cumulative duration, and the category required by the current target-market framework. Do not reuse a legacy category label without checking the current standard and regulator matrix.
  3. Write functional acceptance criteria. Include the property that actually controls safety: seal load, latch retention, dimensional fit, optical transmission, torque, impact, leakage, or another device-specific measure.
  4. Request grade-level evidence. Obtain the exact commercial grade, color, change-control policy, sterilization data with conditions, biological-evaluation support, and use restrictions.
  5. Review molding implications. High-temperature grades may require different drying, melt delivery, mold-temperature control, gating, venting, draft, and tool materials. These are project inputs, not assumed capabilities.
  6. Mold representative parts. Use production-intent formulation, geometry, process window, surface finish, joining, markings, and packaging.
  7. Test across worst credible exposure. Assess the validated maximum dose or cycle conditions, claimed number of reprocessing cycles, and relevant aging points—not only one nominal exposure.
  8. Re-evaluate changes. A material, color, supplier, process, mold repair, sterilization, packaging, or cleaning change should trigger a documented risk assessment and a decision on additional verification or validation.

This sequence prevents a common dead end: selecting a transparent or high-strength resin first, cutting the tool, and only then discovering that the required steam life, radiation dose, color stability, residual release, or contact category is outside the supplier’s support.

For supplier scoping only—not as proof of certification, cleanroom status, sterilization validation, or device-specific capability—HordRT’s medical-device manufacturing overview, medical injection molding guide, and plastic injection molding service can help frame early questions about material, tooling, molding, and inspection. The program still needs site- and project-specific evidence for every regulated or validation claim.

Frequently Asked Questions

Does “medical grade” mean the molded part is biocompatible?

No. It usually describes a supplier-controlled grade and a defined support package. The finished device still requires a biological evaluation appropriate to its materials, processing, sterilization, surface condition, body contact, duration, and target market.[9][10]

How many autoclave cycles can a medical plastic survive?

There is no polymer-family answer. Use cycle-retention data for the exact grade, temperature, dwell, cleaning sequence, molded geometry, and acceptance criterion. A supplier may report more than 1,000 cycles for a particular PPSU offering, while another grade may be approved only for a stated steam temperature or much narrower use.[3][5]

Can gamma-qualified material be changed to e-beam without testing?

Not automatically. Both are ionizing radiation, but dose rate, penetration, dose distribution, packaging, and aging response can differ. Assess the proposed process on the finished device at the relevant maximum exposure.[8]

Is EtO compatible with all plastics because it is low-temperature?

No. Low process temperature can broaden the material options, but device function, packaging, residual EO/ECH, aeration, and release still require validation.[6][7]

Conclusion

Sterilization compatibility is not a checkmark beside a polymer name. It is a verified relationship among an exact medical grade, a molded and finished device, a defined sterilization process, a claimed service life, and measurable acceptance criteria.

Choose the method and exposure before the resin. Use supplier data to screen grades, not to certify the device. Then validate production-intent molded parts through the maximum sterilization exposure, aging, and real functional demands. That is how medical grade plastics injection molding moves from a plausible material choice to defensible device evidence.

Sources

[1] U.S. FDA: Recognition of AAMI TIR17:2024, Compatibility of Materials Subjected to Sterilization. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfstandards/detail.cfm?standard__identification_no=45932

[2] ISO: ISO 17665:2024—Moist Heat Sterilization of Health Care Products. https://www.iso.org/standard/80271.html

[3] Syensqo: Radel PPSU Applications—Healthcare Sterilization and Contact Limits. https://www.syensqo.com/en/brands/radel-ppsu/applications

[4] SABIC: ULTEM HU1004 Resin Product Feature for Healthcare Applications. https://www.sabic.com/zh/Images/ULTEM-HU1004-Resin-Product-Feature-EN_tcm11-5080.pdf

[5] Covestro: Makrolon 2458 Medical Polycarbonate Product Data. https://solutions.covestro.com/en/products/makrolon/makrolon-2458_000000000057533971

[6] U.S. FDA: Sterilization for Medical Devices. https://www.fda.gov/medical-devices/general-hospital-devices-and-supplies/sterilization-medical-devices

[7] ISO: ISO 10993-7:2026—Ethylene Oxide Sterilization Residuals. https://www.iso.org/standard/84824.html

[8] International Atomic Energy Agency: Radiation Effects on Polymer Materials Commonly Used in Medical Devices. https://nucleus.iaea.org/sites/diif/resources/PublishingImages/Pages/default/Radiation%20Effects%20on%20Polymer%20Materials.pdf

[9] U.S. FDA: Recognition of ISO 10993-1:2025, Biological Evaluation of Medical Devices—Part 1. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfstandards/detail.cfm?standard__identification_no=47116

[10] U.S. FDA: Use of International Standard ISO 10993-1—Guidance for Industry and FDA Staff. https://www.fda.gov/media/142959/download

Leave a Reply

Your email address will not be published. Required fields are marked *